NYSE:USNA - USANA Health Sciences Stock Price, Price Target & More

Get Started

$119.60 +0.55 (+0.46 %)

(As of 05/24/2018 02:24 AM ET)

Previous Close$119.60

Today's Range$119.30 - $121.00

52-Week Range$52.80 - $121.15

Volume150,183 shs

Average Volume129,489 shs

Market Capitalization$2.87 billion

P/E Ratio29.46

Dividend YieldN/A

Beta0.76

About USANA Health Sciences (NYSE:USNA)

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé?beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medicinals & botanicals

Sub-IndustryPersonal Products

SectorMedical

SymbolNYSE:USNA

CUSIP90328M10

Webwww.usana.com

Phone801-954-7100

Debt

Debt-to-Equity RatioN/A

Current Ratio2.90

Quick Ratio2.36

Price-To-Earnings

Trailing P/E Ratio29.46

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$1.05 billion

Price / Sales2.76

Cash Flow$4.8796 per share

Price / Cash24.51

Book Value$16.58 per share

Price / Book7.21

Profitability

EPS (Most Recent Fiscal Year)$4.06

Net Income$62.53 million

Net Margins6.47%

Return on Equity27.92%

Return on Assets20.26%

Miscellaneous

Employees1,810

Outstanding Shares24,180,000

USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences declared that its Board of Directors has initiated a stock repurchase program on Wednesday, July 26th 2017, which permits the company to repurchase $64,600,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 46% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's board believes its shares are undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) issued its quarterly earnings results on Tuesday, April, 24th. The company reported $1.19 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.05 by $0.14. The company earned $292 million during the quarter, compared to analyst estimates of $268.93 million. USANA Health Sciences had a net margin of 6.47% and a return on equity of 27.92%. The business's revenue for the quarter was up 14.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 EPS. View USANA Health Sciences' Earnings History.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences updated its FY18 earnings guidance on Tuesday, April, 24th. The company provided EPS guidance of $4.25-4.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.37. The company issued revenue guidance of $1.13-1.17 billion, compared to the consensus revenue estimate of $1.12 billion.

What price target have analysts set for USNA?

2 brokers have issued twelve-month price objectives for USANA Health Sciences' stock. Their predictions range from $95.00 to $95.00. On average, they expect USANA Health Sciences' share price to reach $95.00 in the next year. View Analyst Ratings for USANA Health Sciences.

Who are some of USANA Health Sciences' key competitors?

Some companies that are related to USANA Health Sciences include Stada Arzneimittel (STDAF), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), MediWound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), Pharmacyte Biotech (PMCB), China Jo-Jo Drugstores (CJJD), GLG Life Tech (GLGLF), Cyanotech (CYAN), ImmuDyne (IMMD), FitLife Brands (FTLF), Nutra Pharma (NPHC), Tauriga Sciences (TAUG) and True Drinks (TRUU).

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:

Dr. Myron W. Wentz, Founder & Chairman (Age 77)
Mr. Kevin G. Guest, CEO & Director (Age 55)
Mr. Jim Brown, Pres & COO (Age 49)
Mr. James H. Bramble, Chief Legal Officer, Gen. Counsel & Corp. Sec. (Age 48)
Mr. Daniel A. Macuga Jr., Chief Communications & Marketing Officer (Age 48)

Has USANA Health Sciences been receiving favorable news coverage?

Media coverage about USNA stock has been trending somewhat positive this week, according to Accern. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. USANA Health Sciences earned a media sentiment score of 0.21 on Accern's scale. They also assigned news headlines about the company an impact score of 45.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.45%), Dimensional Fund Advisors LP (3.23%), Schroder Investment Management Group (1.38%), Matarin Capital Management LLC (0.65%), Hood River Capital Management LLC (0.63%) and Russell Investments Group Ltd. (0.57%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, Dave Wentz, David Mulham Mulham, Deborah Woo, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

Which major investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, BNP Paribas Arbitrage SA, UBS Group AG, Hays Advisory LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Guggenheim Capital LLC, Camarda Financial Advisors LLC and New York State Common Retirement Fund. Company insiders that have sold USANA Health Sciences company stock in the last year include Daniel A Macuga, David Mulham Mulham, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

Which major investors are buying USANA Health Sciences stock?

USNA stock was acquired by a variety of institutional investors in the last quarter, including Matarin Capital Management LLC, Hood River Capital Management LLC, BlackRock Inc., Russell Investments Group Ltd., Millennium Management LLC, Fort L.P., Schwab Charles Investment Management Inc. and Mackay Shields LLC. View Insider Buying and Selling for USANA Health Sciences.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $119.60.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $2.87 billion and generates $1.05 billion in revenue each year. The company earns $62.53 million in net income (profit) each year or $4.06 on an earnings per share basis. USANA Health Sciences employs 1,810 workers across the globe.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]

MarketBeat Community Rating for USANA Health Sciences (USNA)

Community Ranking:		1.9 out of 5 ()
Outperform Votes:		156 (Vote Outperform)
Underperform Votes:		258 (Vote Underperform)
Total Votes:		414

MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.

USANA Health Sciences (NYSE:USNA) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

2 Wall Street analysts have issued ratings and price targets for USANA Health Sciences in the last 12 months. Their average twelve-month price target is $95.00, suggesting that the stock has a possible downside of 20.57%. The high price target for USNA is $95.00 and the low price target for USNA is $95.00. There are currently 2 hold ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Buy	Buy
Consensus Rating Score:	2.00	2.00	2.50	3.00
Ratings Breakdown:	0 Sell Rating(s) 2 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$95.00	$95.00	$95.00	$80.00
Price Target Upside:	20.57% downside	4.19% downside	24.26% upside	29.14% upside

USANA Health Sciences (NYSE:USNA) Consensus Price Target History

Price Target History for USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE:USNA) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/23/2018	Pivotal Research	Downgrade	Buy ➝ Hold	$95.00	High
1/24/2018	Sidoti	Downgrade	Buy ➝ Neutral		Medium
7/28/2016	DA Davidson	Boost Price Target	Neutral	$135.00 ➝ $150.00	N/A

(Data available from 5/24/2016 forward)

USANA Health Sciences (NYSE:USNA) Earnings History and Estimates Chart

Earnings by Quarter for USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE:USNA) Earnings Estimates

Current Year EPS Consensus Estimate: $4.4 EPS

USANA Health Sciences (NYSE USNA) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/23/2018		$1.12					N/A
4/24/2018	Q1 2018	$1.05	$1.19	$268.93 million	$292.00 million	View	N/A
2/6/2018	Q4 2017	$1.00	$1.11	$258.67 million	$273.11 million	View	N/A
10/24/2017	Q3 2017	$0.91	$1.02	$259.52 million	$261.77 million	View	N/A
7/25/2017	Q2 2017	$1.06	$0.98	$273.61 million	$257.10 million	View	N/A
5/2/2017	Q1 2017	$0.92	$0.91		$255.32 million	View	Listen
2/7/2017	Q416	$0.94	$0.87	$253.52 million	$252.90 million	View	Listen
10/25/2016	Q316	$2.13	$2.40	$263.37 million	$254.22 million	View	Listen
7/26/2016	Q2	$2.05	$2.07	$256.66 million	$258.50 million	View	Listen
5/3/2016	Q116	$1.81	$1.77	$244.05 million	$240.45 million	View	Listen
2/9/2016	Q415	$2.00	$1.83	$250.82 million	$232.60 million	View	Listen
11/3/2015	Q315	$1.76	$1.92	$230.79 million	$233.30 million	View	Listen
8/4/2015	Q215	$1.60	$1.92	$211.86 million	$233.20 million	View	Listen
5/5/2015	Q1	$1.30	$1.50	$198.21 million	$219.40 million	View	Listen
2/10/2015	Q414	$1.93	$1.65	$219.10 million	$227.90 million	View	Listen
10/28/2014	Q314	$1.37	$1.47	$190.50 million	$191.90 million	View	Listen
7/29/2014	Q214	$1.50	$1.36	$198.30 million	$188.30 million	View	Listen
4/29/2014	Q114	$1.30	$1.15	$185.85 million	$182.40 million	View	Listen
2/5/2014	Q413	$1.22	$1.41	$175.53 million	$186.30 million	View	Listen
10/23/2013	Q313	$1.14	$1.16	$172.40 million	$173.70 million	View	Listen
7/23/2013	Q2 2013	$1.33	$1.72	$176.60 million	$189.10 million	View	Listen
4/23/2013	Q1 2013	$1.16	$1.28	$171.77 million	$169.10 million	View	Listen
2/5/2013	Q4 2012	$1.21	$1.27	$165.80 million	$168.50 million	View	Listen
10/23/2012		$1.06	$1.18			View	N/A
7/24/2012		$0.92	$1.11			View	N/A
4/24/2012	Q1 2012	$0.35	$0.45			View	N/A
2/7/2012		$0.86	$0.87			View	N/A
10/25/2011		$0.76	$0.81			View	N/A
7/26/2011	Q2 2011	$0.40	$0.44			View	N/A
4/26/2011		$0.66	$0.70			View	N/A
2/8/2011		$0.84	$0.75			View	N/A
10/26/2010	Q3 2010	$0.32	$0.40			View	N/A
7/27/2010	Q2 2010	$0.31	$0.34			View	N/A
4/27/2010	Q1 2010	$0.25	$0.31			View	N/A
2/9/2010	Q4 2009	$0.30	$0.33			View	N/A
10/27/2009	Q3 2009	$0.25	$0.25			View	N/A
7/28/2009	Q2 2009	$0.23	$0.29			View	N/A
4/28/2009	Q1 2009	$0.20	$0.22			View	N/A
2/23/2009	Q4 2008	$0.28	$0.28			View	N/A
10/14/2008	Q3 2008	$0.30	$0.25			View	N/A
7/22/2008	Q2 2008	$0.31	$0.31			View	N/A
4/21/2008	Q1 2008	$0.23	$0.23			View	N/A
2/5/2008	Q4 2007	$0.34	$0.33			View	N/A

(Earnings results data provided by Zacks Investment Research)

USANA Health Sciences (NYSE:USNA) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

USANA Health Sciences (NYSE USNA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 48.00%
Institutional Ownership Percentage: 48.85%

Insider Trading History for USANA Health Sciences (NYSE:USNA)

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

USANA Health Sciences (NYSE USNA) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2018	David Mulham Mulham	Insider	Sell	14,733	$113.03	$1,665,270.99	14,733
5/2/2018	G Doug Iiekking	CFO	Sell	510	$105.54	$53,825.40
5/1/2018	Global Ltd Gull	Major Shareholder	Sell	40,000	$105.96	$4,238,400.00
4/3/2018	Global Ltd Gull	Major Shareholder	Sell	40,000	$86.23	$3,449,200.00	11,214,053
3/12/2018	Global Ltd Gull	Major Shareholder	Sell	67,464	$80.84	$5,453,789.76	11,439,646
3/12/2018	Myron W Wentz	Director	Sell	228,000	$81.10	$18,490,800.00
3/9/2018	Myron W Wentz	Director	Sell	78,129	$81.19	$6,343,293.51
3/8/2018	Global Ltd Gull	Major Shareholder	Sell	82,407	$81.24	$6,694,744.68	11,439,646
3/8/2018	Paul A Jones	Insider	Sell	10,696	$81.00	$866,376.00	10,696
3/7/2018	G Doug Iiekking	CFO	Sell	2,423	$81.05	$196,384.15	2,423
3/2/2018	Myron W Wentz	Director	Sell	28,050	$76.14	$2,135,727.00
3/1/2018	Global Ltd Gull	Major Shareholder	Sell	11,950	$75.77	$905,451.50	11,550,103
2/15/2018	Myron W Wentz	Director	Sell	53,372	$76.01	$4,056,805.72
2/15/2018	Walter Noot	Insider	Sell	3,075	$77.00	$236,775.00	3,075
2/14/2018	Global Ltd Gull	Major Shareholder	Sell	34,205	$75.70	$2,589,318.50	11,581,220
2/13/2018	Myron W Wentz	Director	Sell	28,405	$75.39	$2,141,452.95
2/12/2018	Global Ltd Gull	Major Shareholder	Sell	10,287	$75.39	$775,536.93	11,641,846
2/9/2018	Global Ltd Gull	Major Shareholder	Sell	1,984	$74.78	$148,363.52	11,641,846
2/6/2018	Myron W Wentz	Director	Sell	38,223	$71.51	$2,733,326.73
2/5/2018	Global Ltd Gull	Major Shareholder	Sell	8,344	$72.28	$603,104.32	11,682,053
2/2/2018	Global Ltd Gull	Major Shareholder	Sell	2,753	$74.24	$204,382.72	11,682,053
11/22/2017	Global Ltd Gull	Major Shareholder	Sell	45,216	$66.44	$3,004,151.04	11,694,053
11/21/2017	Myron W Wentz	Director	Sell	164,916	$66.40	$10,950,422.40
11/20/2017	Global Ltd Gull	Major Shareholder	Sell	39,751	$66.11	$2,627,938.61	11,896,290
11/17/2017	Myron W Wentz	Director	Sell	7,895	$66.03	$521,306.85
11/16/2017	Global Ltd Gull	Major Shareholder	Sell	101,929	$66.05	$6,732,410.45	11,996,192
11/15/2017	Myron W Wentz	Director	Sell	11,835	$66.07	$781,938.45
11/13/2017	Global Ltd Gull	Major Shareholder	Sell	7,289	$66.01	$481,146.89	11,996,192
11/13/2017	Myron W Wentz	Director	Sell	5,304	$66.01	$350,117.04	12,011,418
11/9/2017	Myron W Wentz	Director	Sell	1,985	$66.01	$131,029.85	12,011,418
11/2/2017	Global Ltd Gull	Major Shareholder	Sell	43,292	$65.25	$2,824,803.00	12,053,403
11/1/2017	Myron W Wentz	Director	Sell	17,107	$65.42	$1,119,139.94
10/30/2017	Global Ltd Gull	Major Shareholder	Sell	93,443	$67.08	$6,268,156.44	12,089,267
10/30/2017	Myron W Wentz	Director	Sell	21,209	$66.11	$1,402,126.99
10/26/2017	Gilbert A Fuller	Director	Sell	1,710	$67.01	$114,587.10	1,710
10/26/2017	Global Ltd Gull	Major Shareholder	Sell	60,871	$67.39	$4,102,096.69	12,089,267
10/3/2017	Myron W Wentz	Director	Sell	40,000	$57.54	$2,301,600.00
9/15/2017	Myron W Wentz	Director	Sell	28,788	$57.19	$1,646,385.72
9/14/2017	Global Ltd Gull	Major Shareholder	Sell	79,294	$57.61	$4,568,127.34	12,272,013
9/14/2017	Myron W Wentz	Director	Sell	34,226	$57.51	$1,968,337.26
9/5/2017	Global Ltd Gull	Major Shareholder	Sell	40,000	$58.41	$2,336,400.00	12,326,224
8/30/2017	Daniel A Macuga	Insider	Sell	11,992	$59.00	$707,528.00	11,992
8/28/2017	Daniel A Macuga	Insider	Sell	5,751	$60.00	$345,060.00	2,077
8/23/2017	Jim Brown	COO	Sell	16,574	$58.84	$975,214.16	2,175
8/23/2017	Kevin Guest	Insider	Sell	29,934	$59.01	$1,766,405.34	10,549
8/21/2017	James Bramble	Insider	Sell	18,298	$57.01	$1,043,168.98	20,374
8/2/2017	Global Ltd Gull	Major Shareholder	Sell	14,533	$56.71	$824,166.43	12,352,753
8/2/2017	Myron W Wentz	Director	Sell	40,000	$56.59	$2,263,600.00
8/1/2017	Global Ltd Gull	Major Shareholder	Sell	25,467	$56.52	$1,439,394.84	12,352,753
7/31/2017	Gilbert A Fuller	Director	Sell	1,483	$57.67	$85,524.61	1,483
7/5/2017	Myron W Wentz	Director	Sell	40,000	$64.15	$2,566,000.00
6/2/2017	Myron W Wentz	Director	Sell	40,000	$64.99	$2,599,600.00
6/1/2017	Paul A Jones	Insider	Sell	9,851	$64.50	$635,389.50	6,020
5/11/2017	Gilbert A Fuller	Director	Sell	4,884	$64.38	$314,431.92	4,884
5/1/2017	Myron W Wentz	Director	Sell	40,000	$56.39	$2,255,600.00
4/5/2017	Global Ltd Gull	Major Shareholder	Sell	16,436	$56.54	$929,291.44	12,524,696
4/5/2017	Myron W Wentz	Director	Sell	40,000	$56.81	$2,272,400.00
4/4/2017	Global Ltd Gull	Major Shareholder	Sell	10,040	$56.69	$569,167.60	12,524,696
4/3/2017	Global Ltd Gull	Major Shareholder	Sell	13,524	$57.22	$773,843.28	12,524,696
3/8/2017	Global Ltd Gull	Major Shareholder	Sell	20,000	$57.15	$1,143,000.00	12,538,220
2/8/2017	Global Ltd Gull	Major Shareholder	Sell	20,000	$55.87	$1,117,400.00	12,558,220
1/11/2017	Myron W Wentz	Director	Sell	20,000	$61.04	$1,220,800.00
12/14/2016	Myron W Wentz	Director	Sell	20,000	$61.41	$1,228,200.00
11/9/2016	Myron W Wentz	Director	Sell	10,000	$123.99	$1,239,900.00
10/12/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$146.35	$1,463,500.00	6,319,110
9/14/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$134.67	$1,346,700.00	6,329,110
9/8/2016	Deborah Woo	Insider	Sell	1,058	$140.00	$148,120.00	2,537
8/30/2016	Paul A Jones	CFO	Sell	5,067	$138.50	$701,779.50	5,067
8/23/2016	Deborah Woo	Insider	Sell	2,621	$138.94	$364,161.74	3,982
8/23/2016	Robert Auciaux	Director	Sell	2,317	$138.79	$321,576.43	2,317
8/19/2016	Deborah Woo	Insider	Sell	4,590	$133.12	$611,020.80	5,660
8/18/2016	Deborah Woo	Insider	Sell	5,041	$131.15	$661,127.15
8/16/2016	James Bramble	Insider	Sell	9,339	$131.33	$1,226,490.87	2,482
8/16/2016	Jim Brown	COO	Sell	9,104	$131.36	$1,195,901.44	1,513
8/15/2016	Kevin Guest	Insider	Sell	16,285	$131.08	$2,134,637.80	16,285
8/10/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$135.08	$1,350,800.00	6,339,110
8/1/2016	Gilbert A. Fuller	Director	Sell	859	$137.07	$117,743.13
7/13/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$118.96	$1,189,600.00	6,349,110
6/8/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$123.47	$1,234,700.00	6,359,110
6/7/2016	Dave Wentz	Insider	Sell	10,000	$125.09	$1,250,900.00	388,615
5/11/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$122.67	$1,226,700.00	6,369,110
4/13/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$121.82	$1,218,200.00	6,379,110
3/9/2016	Myron W Wentz	Director	Sell	10,000	$116.07	$1,160,700.00
3/4/2016	Jerry G Mcclain	Director	Sell	767	$118.17	$90,636.39	767
2/24/2016	Gilbert A Fuller	Director	Sell	728	$113.22	$82,424.16	728
2/10/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$96.37	$963,700.00	6,399,110
1/13/2016	Global Ltd Gull	Major Shareholder	Sell	10,000	$121.04	$1,210,400.00	6,409,110
12/17/2015	Rick Stambaugh	insider	Sell	7,059	$130.18	$918,940.62
12/16/2015	Doug Braun	CMO	Sell	10,907	$130.80	$1,426,635.60
12/15/2015	Dave Wentz	Insider	Sell	6,000	$130.59	$783,540.00	442,765
12/15/2015	Doug Braun	CMO	Sell	2,748	$132.00	$362,736.00
12/9/2015	Myron W Wentz	Director	Sell	10,000	$133.18	$1,331,800.00
11/11/2015	Global Ltd Gull	Major Shareholder	Sell	10,000	$133.71	$1,337,100.00	6,429,110
10/1/2015	Myron W Wentz	Director	Sell	10,000	$131.85	$1,318,500.00
9/10/2015	Myron W Wentz	Director	Sell	7,000	$138.32	$968,240.00
8/27/2015	Deborah Woo	insider	Sell	1,527	$150.00	$229,050.00
8/17/2015	Paul A Jones	CFO	Sell	7,719	$162.21	$1,252,098.99
8/12/2015	Myron W Wentz	Director	Sell	7,000	$159.84	$1,118,880.00
7/8/2015	Myron W Wentz	Director	Sell	7,000	$138.28	$967,960.00
6/10/2015	Myron W Wentz	Director	Sell	7,000	$133.75	$936,250.00
6/9/2015	Deborah Woo	Insider	Sell	3,656	$132.06	$482,811.36
5/14/2015	Deborah Woo	Insider	Sell	3,569	$124.00	$442,556.00
5/12/2015	Kevin Guest	Insider	Sell	2,858	$120.00	$342,960.00
5/11/2015	Daniel A Macuga	Insider	Sell	4,231	$125.64	$531,582.84
5/11/2015	Jim Brown	COO	Sell	7,860	$124.46	$978,255.60
4/8/2015	Global Ltd Gull	Major Shareholder	Sell	7,000	$113.54	$794,780.00
2/12/2015	Robert Auciaux	Director	Sell	5,028	$100.18	$503,705.04
1/14/2015	Myron W Wentz	Director	Sell	7,000	$101.32	$709,240.00
12/16/2014	Doug Braun	CMO	Sell	9,969	$101.01	$1,006,968.69
12/10/2014	Myron W Wentz	Director	Sell	102,755	$100.25	$10,301,188.75
12/8/2014	Myron W Wentz	Director	Sell	184,245	$104.65	$19,281,239.25
11/3/2014	Dave Wentz	Insider	Sell	19,780	$114.68	$2,268,370.40
10/31/2014	Ronald S Poelman	Director	Sell	4,491	$112.53	$505,372.23
10/30/2014	Paul A Jones	CFO	Sell	10,823	$105.10	$1,137,497.30
10/8/2014	Myron W Wentz	Director	Sell	7,000	$76.52	$535,640.00
9/10/2014	Myron W Wentz	Director	Sell	7,000	$71.53	$500,710.00
8/25/2014	Dave Wentz	Insider	Sell	5,141	$73.30	$376,835.30
7/9/2014	Myron W Wentz	Director	Sell	7,000	$78.95	$552,650.00
6/13/2014	Dave Wentz	Insider	Sell	5,301	$75.51	$400,278.51
6/11/2014	Myron W Wentz	Director	Sell	7,000	$74.69	$522,830.00
6/10/2014	Daniel A Macuga	Insider	Sell	6,654	$75.01	$499,116.54
5/30/2014	Deborah Woo	Insider	Sell	1,028	$73.00	$75,044.00
5/28/2014	Dave Wentz	Insider	Sell	5,141	$73.03	$375,447.23
5/28/2014	Jerry G Mcclain	Director	Sell	1,217	$72.12	$87,770.04
5/22/2014	Kevin Guest	Insider	Sell	10,160	$71.15	$722,884.00
5/21/2014	Kevin Guest	Insider	Sell	2,475	$71.00	$175,725.00
5/19/2014	James Bramble	Insider	Sell	5,919	$70.02	$414,448.38
5/14/2014	Myron Wentz	Director	Sell	14,000	$73.78	$1,032,920.00
5/12/2014	Deborah Woo	Insider	Sell	11,336	$70.03	$793,860.08
5/5/2014	Deborah Woo	Insider	Sell	3,512	$71.00	$249,352.00
3/4/2014	Myron Wentz	Director	Sell	63,805	$72.69	$4,637,985.45
2/11/2014	Doug Braun	CMO	Sell	8,139	$70.46	$573,473.94
11/13/2013	Myron Wentz	Director	Sell	7,000	$67.68	$473,760.00
10/9/2013	Holdings Ltd Gull	major shareholder	Sell	7,000	$80.08	$560,560.00	6,581,167
9/11/2013	Deborah Woo	Insider	Sell	1,340	$79.01	$105,873.40
9/11/2013	Holdings Ltd Gull	major shareholder	Sell	7,000	$78.19	$547,330.00	6,588,167
9/5/2013	Dave Wentz	Insider	Sell	13,704	$77.93	$1,067,952.72	473,955
9/3/2013	Dave Wentz	Insider	Sell	32,174	$78.10	$2,512,789.40	473,955
8/14/2013	Holdings Ltd Gull	major shareholder	Sell	7,000	$80.34	$562,380.00	6,595,167
8/1/2013	Deborah Woo	Insider	Sell	1,386	$85.00	$117,810.00
7/26/2013	Paul A Jones	CFO	Sell	5,047	$78.01	$393,716.47
7/25/2013	Kevin Guest	Insider	Sell	19,290	$73.20	$1,412,028.00
7/25/2013	Ronald S Poelman	Director	Sell	6,380	$73.20	$467,016.00
7/10/2013	Holdings Ltd Gull	Major Shareholder	Sell	7,000	$78.22	$547,540.00
6/12/2013	Holdings Ltd Gull	Major Shareholder	Sell	7,000	$70.96	$496,720.00
5/9/2013	Robert Auciaux	Director	Sell	2,664	$55.92	$148,970.88
5/8/2013	Holdings Ltd Gull	Major Shareholder	Sell	7,000	$56.59	$396,130.00
4/10/2013	Holdings Ltd Gull	Major Shareholder	Sell	7,000	$47.45	$332,150.00
8/8/2012	Myron W Wentz	Director	Sell	7,000	$44.21	$309,470.00

(Data available from 1/1/2013 forward)

USANA Health Sciences (NYSE USNA) News Headlines

Source:

Date	Headline
	USANA remains on top after taking home multiple local and international awards finance.yahoo.com - May 22 at 4:12 PM
	USANA Health Sciences (USNA) Insider David Mulham Mulham Sells 14,733 Shares www.americanbankingnews.com - May 18 at 7:29 PM
	Comparing ChromaDex (CDXC) and USANA Health Sciences (USNA) www.americanbankingnews.com - May 17 at 3:23 PM
	Analyzing USANA Health Sciences (USNA) & ChromaDex (CDXC) www.americanbankingnews.com - May 14 at 9:16 PM
	Contrasting True Drinks (TRUU) and USANA Health Sciences (USNA) www.americanbankingnews.com - May 12 at 5:11 PM
	Reviewing Stada Arzneimittel (STDAF) & USANA Health Sciences (USNA) www.americanbankingnews.com - May 12 at 12:03 PM
	ChromaDex (CDXC) & USANA Health Sciences (USNA) Head-To-Head Comparison www.americanbankingnews.com - May 9 at 11:20 PM
	USANA Manufacturing Facility Passes Rigorous Audit finance.yahoo.com - May 7 at 9:35 AM
	Today's Research Reports on Trending Tickers: Herbalife Nutrition and USANA Health Sciences finance.yahoo.com - May 4 at 9:39 AM
	G Doug Iiekking Sells 510 Shares of USANA Health Sciences (USNA) Stock www.americanbankingnews.com - May 3 at 8:45 PM
	Insider Selling: USANA Health Sciences (USNA) Major Shareholder Sells 40,000 Shares of Stock www.americanbankingnews.com - May 3 at 7:33 PM
	USANA Health Sciences (USNA) Rating Increased to Buy at ValuEngine www.americanbankingnews.com - May 2 at 3:12 PM
	Edited Transcript of USNA earnings conference call or presentation 25-Apr-18 3:00pm GMT finance.yahoo.com - May 1 at 4:10 PM
	Form 4 USANA HEALTH SCIENCES For: Apr 23 Filed by: FULLER GILBERT A www.streetinsider.com - April 26 at 4:14 PM
	BRIEF-Usana Health Sciences Q1 Earnings Per Share $1.19 www.reuters.com - April 26 at 4:14 PM
	USANA's (USNA) CEO Kevin Guest on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - April 26 at 9:33 AM
	USANA Health Sciences (USNA) Raised to A- at TheStreet www.americanbankingnews.com - April 26 at 8:00 AM
	At $96.05, Is USANA Health Sciences Inc (NYSE:USNA) A Buy? finance.yahoo.com - April 25 at 4:23 PM
	USANA Health Sciences (USNA) Announces Earnings Results www.americanbankingnews.com - April 25 at 1:24 PM
	USANA Health Sciences Profit Climbs In Q1 www.nasdaq.com - April 25 at 9:57 AM
	USANA Health: 1Q Earnings Snapshot finance.yahoo.com - April 25 at 9:57 AM
	USANA Health Sciences (USNA) Releases FY18 Earnings Guidance www.americanbankingnews.com - April 24 at 5:02 PM
	USANA Health Sciences Reports Record First Quarter 2018 Net Sales and Increases 2018 Outlook finance.yahoo.com - April 24 at 4:24 PM
	USANA Health Sciences (USNA) Downgraded by Pivotal Research www.americanbankingnews.com - April 23 at 10:22 AM
	USANA Health Sciences (USNA) Set to Announce Earnings on Monday www.americanbankingnews.com - April 23 at 4:28 AM
	USANA Health Sciences (USNA) & ChromaDex (CDXC) Head-To-Head Contrast www.americanbankingnews.com - April 19 at 5:40 AM
	MediWound (MDWD) and USANA Health Sciences (USNA) Head-To-Head Survey www.americanbankingnews.com - April 9 at 7:14 AM
	Comparing USANA Health Sciences (USNA) & Foamix Pharmaceuticals (FOMX) www.americanbankingnews.com - April 8 at 1:16 AM
	USANA Health Sciences (USNA) Lifted to "Sell" at BidaskClub www.americanbankingnews.com - April 7 at 3:21 PM
	Head to Head Review: MediWound (MDWD) & USANA Health Sciences (USNA) www.americanbankingnews.com - April 6 at 9:07 PM
	USANA Health Sciences (USNA) Upgraded at BidaskClub www.americanbankingnews.com - April 4 at 11:26 PM
	USANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 40,000 Shares www.americanbankingnews.com - April 4 at 10:22 PM
	USANA Health Sciences (USNA) Downgraded by BidaskClub to Sell www.americanbankingnews.com - April 2 at 9:34 AM
	Insider Selling: USANA Health Sciences, Inc. (USNA) Insider Sells 10,696 Shares of Stock www.americanbankingnews.com - March 12 at 7:39 PM
	Myron W. Wentz Sells 78,129 Shares of USANA Health Sciences, Inc. (USNA) Stock www.americanbankingnews.com - March 12 at 7:22 PM
	USANA Health Sciences, Inc. (USNA) Major Shareholder Sells $5,453,789.76 in Stock www.americanbankingnews.com - March 12 at 7:22 PM
	USANA Health Sciences, Inc. (USNA) Major Shareholder Global Ltd Gull Sells 82,407 Shares www.americanbankingnews.com - March 12 at 7:21 PM
	Insider Selling: USANA Health Sciences, Inc. (USNA) Director Sells 228,000 Shares of Stock www.americanbankingnews.com - March 12 at 7:20 PM
	USANA Named Top Rated Direct Selling Brand for Fifth Time finance.yahoo.com - March 12 at 10:24 AM
	Insider Selling: USANA Health Sciences, Inc. (USNA) CFO Sells 2,423 Shares of Stock www.americanbankingnews.com - March 8 at 12:31 AM
	Form 4 USANA HEALTH SCIENCES For: Mar 01 Filed by: Gull Global Ltd www.streetinsider.com - March 6 at 9:40 AM
	Global Ltd Gull Sells 11,950 Shares of USANA Health Sciences, Inc. (USNA) Stock www.americanbankingnews.com - March 5 at 9:11 PM
	USANA Health Sciences, Inc. (USNA) Director Myron W. Wentz Sells 28,050 Shares www.americanbankingnews.com - March 5 at 9:10 PM
	Martingale Asset Management L P Has $2.59 Million Stake in USANA Health Sciences, Inc. (USNA) www.americanbankingnews.com - March 3 at 11:50 AM
	Arrowstreet Capital Limited Partnership Purchases 70,917 Shares of USANA Health Sciences, Inc. (USNA) www.americanbankingnews.com - March 2 at 5:04 AM
	Usana Health Sciences Inc (USNA) Files 10-K for the Fiscal Year Ended on December 31, 2017 finance.yahoo.com - February 28 at 4:43 PM
	USANA Health Sciences, Inc. (USNA) Holdings Boosted by Fort L.P. www.americanbankingnews.com - February 27 at 3:37 PM
	Herbalife’s 4Q17 Sales Beat Estimate, Returned to Growth finance.yahoo.com - February 23 at 4:38 PM
	Herbalife Crushed 4Q17 Earnings Estimate, Marking 29% Growth finance.yahoo.com - February 23 at 4:38 PM
	Why Herbalife Stock Fell despite Strong 4Q17 Results finance.yahoo.com - February 23 at 4:38 PM

USANA Health Sciences (NYSE:USNA) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

USANA Health Sciences (NYSE:USNA) Income Statement, Balance Sheet and Cash Flow Statement

USANA Health Sciences (NYSE USNA) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff